Fatty acid transport protein 4 (FATP4) is a fatty acyl-CoA synthetase that preferentially activates very long chain fatty acid substrates, such as C24:0, to their CoA derivatives. To gain better insight into the physiological functions of FATP4, we established dermal fibroblast cell lines from FATP4-deficient wrinkle-free mice and wild type (w.t.) mice. FATP4 ؊/؊ fibroblasts had no detectable FATP4 protein by Western blot. Compared with w.t. fibroblasts, cells lacking FATP4 had an 83% decrease in C24:0 activation. Peroxisomal degradation of C24:0 was reduced by 58%, and rates of C24:0 incorporation into major phospholipid species (54 -64% decrease), triacylglycerol (64% decrease), and cholesterol esters (58% decrease) were significantly diminished. Because these lipid metabolic processes take place in different subcellular organelles, we used immunofluorescence and Western blotting of subcellular fractions to investigate the distribution of FATP4 protein and measured enzyme activity in fractions from w.t. and FATP4 ؊/؊ fibroblasts. FATP4 protein and acyl-CoA synthetase activity localized to multiple organelles, including mitochondria, peroxisomes, endoplasmic reticulum, and the mitochondria-associated membrane fraction. We conclude that in murine skin fibroblasts, FATP4 is the major enzyme producing very long chain fatty acid-CoA for lipid metabolic pathways. Although FATP4 deficiency primarily affected very long chain fatty acid metabolism, mutant fibroblasts also showed reduced uptake of a fluorescent long chain fatty acid and reduced levels of long chain polyunsaturated fatty acids. FATP4-deficient cells also contained abnormal neutral lipid droplets. These additional defects indicate that metabolic abnormalities in these cells are not limited to very long chain fatty acids.Fatty acids containing 22 or more carbon atoms are referred to as very long chain fatty acids (VLCFA).2 VLCFA are normal constituents of membrane lipids but are particularly abundant in brain, testis, and skin (1-3). Fatty acids, including VLCFA, cannot participate in most metabolic processes unless they are first activated to their CoA derivatives (4). Once activated, however, fatty acids can be degraded to release stored energy or incorporated into glycerolipids, phospholipids, sphingolipids, glycolipids, cholesterol esters, and other complex lipids. Certain acyl-CoAs also serve as substrates for protein acylation and/or function as regulatory molecules. Thus, the fatty acid activation reaction is central to normal cellular lipid metabolism.The acyl-CoA synthetase (ACS) enzyme family catalyzes this essential reaction (4). Because fatty acid chain lengths vary from 2 to more than 30 carbon atoms, different ACSs capable of activating short, medium, long, and very long chain fatty acids have evolved. Based on analysis of amino acid sequence homology, we estimate that mammalian genomes encode at least 25 different ACSs.3 Further analysis of highly conserved domains within these sequences allowed us to group the enzymes into families (5). We ...